OPTN Protein (AA 1-300) (His tag)
-
- Target Alle OPTN Proteine anzeigen
- OPTN (Optineurin (OPTN))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-300
-
Spezies
- Maus
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- Dieses OPTN Protein ist gelabelt mit His tag.
- Applikation
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Sequenz
- Met1-Ser300
- Produktmerkmale
- Recombinant Optineurin (OPTN), Prokaryotic expression, Met1-Ser300, N-terminal His Tag
- Reinheit
- > 97 %
- Top Product
- Discover our top product OPTN Protein
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Isoelectric Point:5.2
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- OPTN (Optineurin (OPTN))
- Andere Bezeichnung
- Optineurin (OPTN Produkte)
- Synonyme
- nrp Protein, fip2 Protein, hip7 Protein, hypl Protein, glc1e Protein, tfiiia-intp Protein, ALS12 Protein, FIP2 Protein, GLC1E Protein, HIP7 Protein, HYPL Protein, NRP Protein, TFIIIA-INTP Protein, Fip2 Protein, 4930441O07Rik Protein, fj52f04 Protein, si:ch211-240l19.3 Protein, wu:fj52f04 Protein, zgc:66386 Protein, zgc:77868 Protein, optineurin Protein, optineurin L homeolog Protein, OPTN Protein, optn Protein, Optn Protein, optn.L Protein
- Hintergrund
- NRP, FIP2, GLC1E, HIP7, HYPL, TFIIIA-INTP, Glaucoma 1,Open Angle,E(Adult-Onset), Huntingtin-interacting protein 7, Optic neuropathy-inducing protein, E3-14.7K-interacting protein
- Molekulargewicht
- 42kDa
- UniProt
- Q8K3K8
- Pathways
- M Phase
-